Featured CE/CME
![House Call 2: Managing OIC in a 76-Year-Old Woman—Gastroenterology and Pain Management Perspectives House Call 2: Managing OIC in a 76-Year-Old Woman—Gastroenterology and Pain Management Perspectives](http://media.mycme.com/images/2016/07/21/oichousecall3thumb_1020108.jpg?format=jpg&zoom=1&quality=70&anchor=middlecenter&height=80&width=80&mode=crop)
House Call 2: Managing OIC in a 76-Year-Old Woman—Gastroenterology and Pain Management Perspectives
Recognize how opioid analgesia affects the gastrointestinal tract and creates risk for opioid-induced constipation (OIC)
![Addressing Cognition in Geriatric Depression: Measurement- and Evidence-Based Care Strategies Addressing Cognition in Geriatric Depression: Measurement- and Evidence-Based Care Strategies](https://media.mcknights.com/images/2011/12/01/wr_12-2-11_214467.jpg?format=jpg&zoom=1&quality=70&anchor=middlecenter&height=80&width=80&mode=crop)
Addressing Cognition in Geriatric Depression: Measurement- and Evidence-Based Care Strategies
In this recording of a live symposium for geriatric psychiatrists that took place on March 8, 2016 in Washington, DC, three leading experts explore the challenges that complicate the treatment of geriatric patients with MDD.
![New Treatment Paradigms for Castrate Resistant Prostate Cancer New Treatment Paradigms for Castrate Resistant Prostate Cancer](http://media.mycme.com/images/2015/09/09/prostatesmall_828429.jpg?format=jpg&zoom=1&quality=70&anchor=middlecenter&height=80&width=80&mode=crop)
New Treatment Paradigms for Castrate Resistant Prostate Cancer
This webcast is intended to improve care of patients with prostate cancer by accelerating adoption of new guidelines and evidence-based practice change.
![Optimizing Outcomes With Oral Antiplatelet Therapies Optimizing Outcomes With Oral Antiplatelet Therapies](http://media.mycme.com/images/2015/10/14/2015antiplateletivptuthumb_848687.png?format=png&zoom=1&quality=70&anchor=middlecenter&height=80&width=80&mode=crop)
Optimizing Outcomes With Oral Antiplatelet Therapies
A review of current guidelines and emerging data on selecting oral antiplatelet therapies, including the optimal duration of dual antiplatelet therapy in selected patients.
![Stroke Prevention in Atrial Fibrillation: Sharing Decision Making for Optimal Anticoagulation Stroke Prevention in Atrial Fibrillation: Sharing Decision Making for Optimal Anticoagulation](https://directory.mcknights.com/webservice/ImageResizer.ashx?n=http%3a%2f%2fimg.publishthis.com%2fimages%2f3_0%2f2014%2f07%2f9%2f1%2f8%2f9183220ec628297d04fd00913b530729_ogimg_large_thumbnail_1.jpg&c=1&h=80&w=80)
Stroke Prevention in Atrial Fibrillation: Sharing Decision Making for Optimal Anticoagulation
Atrial fibrillation (AF) is associated with a 4- to 5-fold increase in the risk for ischemic stroke and systemic embolism, yet less than one-half of patients with AF undergo appropriate risk stratification and anticoagulant therapy.